Abstract:BACKGROUNDCancer is considered a major public health problem worldwide.OBJECTIVEThe aim of this paper is to design and synthesis of novel anticancer agents with potent anticancer activity and minimum side effects.METHODA series of pyrrole derivatives were synthesized, their anti-cancer activity against nine cancer cell lines and two non-cancer cell lines were evaluated by MTT assay, and their cell cycle progression were determined by flow cytometry analysis.RESULTSThe study of the structure-activity relationships revealed that the introduction of the electron-donation groups at the 4th position of the pyrrole ring increased the anti-cancer activity. Among the synthesized compounds, specially the compounds bearing 3,4-dimethoxy phenyl at the 4th position of the pyrrole ring showed potent anti-cancer activity, cpd 19 was the most potent against MGC 80-3, HCT-116 and CHO cell lines (IC50s = 1.0－1.7 μM), cpd 21 was the most potent against HepG2, DU145 and CT-26 cell lines (IC50s = 0.5－0.9 μM), and cpd 15 was the most potent against A549 (IC50 = 3.6 μM). Moreover, these potent compounds showed weak cytotoxicity against HUVEC and NIH/3T3. Thus, the cpds 15, 19 and 21 show potential anti-cancer for further investigation. Furthermore, the flow cytometry analysis revealed that cpd 21 arrested the CT-26 cells at S phase, and induced the cell apoptosis.CONCLUSIONThus, these compounds with the potent anticancer activity and low toxicity have potential for the development of new anticancer chemotherapy agents.

Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds

Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents

Recent Advances in the Development of Pyrazolopyridines As Anticancer Agents

Pharmacological activity and mechanism of pyrazines

Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules

Recent contributions of pyridazine as a privileged scaffold of anticancer agents in medicinal chemistry: An updated review

Pyrimidine-fused Dinitrogenous Penta-heterocycles As a Privileged Scaffold for Anti-Cancer Drug Discovery

Structural Activity Relationship-based Medicinal perceptions of Pyrazoline derivatives as Anti-Cancer Agents: A Review

Medicinal attributes of pyridine scaffold as anticancer targeting agents

Pyrazole Derivatives As Antitumor, Anti-Inflammatory and Antibacterial Agents

Pyrazole Paradigms: Unveiling Synthetic Pathways and Unraveling Anti-Cancer Potential

Synthesis and Anti-cancer Activity of 3-Substituted Benzoyl-4-substituted Phenyl-1H-pyrrole Derivatives.

Synthesis, in Vitro and in Vivo Anticancer Activities of Novel 4-Substituted 1,2-Bis(4-chlorophenyl)-pyrazolidine-3,5-dione Derivatives

Therapeutic Potential of Pyrazole Containing Compounds: an Updated Review

Current Scenario of Pyridine/Quinoline-Sulfonamide Hybrids with Anticancer Potential (A Review)

Construction of C-glycosides of Heterocycles Containing the Pyrimidin-2-amine or the 1H-Pyrazolo[3,4-b]pyridine Moiety and Their Biological Evaluation for Anticancer Activities

Discovery of novel pyrrolo[2,3-d]pyrimidine derivatives as anticancer agents: virtual screening and molecular dynamic studies

Advances in the Research of Pyrazole Derivatives with Antitumor Activity

Six‐membered Aromatic Nitrogen Heterocyclic Anti‐Tumor Agents: Synthesis and Applications

Innovative Pyrazole Hybrids: A New Era in Drug Discovery and Synthesis

Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect